In cervical cancer, both in vitro and in vivo studies have shown that SOX12-induced SNHG15 promotes cervical cancer tumorigenesis and resistance to cisplatin via the miR-4735-3p/HIF1a pathway (65). This evidence concerns the gene SNHG15 and cervical cancer.